These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25066849)

  • 21. Satisfying the requirements of the Food and Drug Administration and Centers for Medicare and Medicare Services.
    Smith JJ; Henderson JA
    J Am Coll Radiol; 2008 Mar; 5(3):189-92. PubMed ID: 18312966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Technology licensing: lessons from the US experience.
    Sobolski GK; Barton JH; Emanuel EJ
    JAMA; 2005 Dec; 294(24):3137-40. PubMed ID: 16380596
    [No Abstract]   [Full Text] [Related]  

  • 23. Gene patenting and licensing: the role of academic researchers and advocacy groups.
    Ledbetter DH
    Genet Med; 2008 May; 10(5):314-9. PubMed ID: 18496028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Academic technology transfer and radiology: a strong partnership for the future.
    Eusemann CD; Sammons BE; Holmes DR; Brady TJ; Erenburg I; Toneguzzo F
    Acad Radiol; 2007 Nov; 14(11):1289-95. PubMed ID: 17964453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The development and dissemination of non-patentable therapies (NPTs).
    Root-Bernstein RS
    Perspect Biol Med; 1995; 39(1):110-7. PubMed ID: 8524618
    [No Abstract]   [Full Text] [Related]  

  • 26. Technology Transfer: From the Research Bench to Commercialization: Part 2: The Commercialization Process.
    Van Norman GA; Eisenkot R
    JACC Basic Transl Sci; 2017 Apr; 2(2):197-208. PubMed ID: 30167567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patenting of genome research results.
    Stolzenburg F; Weinzierl G; Jaenichen HR
    Pharmacogenomics; 2003 Sep; 4(5):633-42. PubMed ID: 12943469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The technology trap.
    Gewin V
    Nature; 2005 Oct; 437(7061):948-9. PubMed ID: 16222269
    [No Abstract]   [Full Text] [Related]  

  • 29. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Commercializing university research. Lessons from the experience of the Wisconsin Alumni Research Foundation.
    Blumenthal D; Epstein S; Maxwell J
    N Engl J Med; 1986 Jun; 314(25):1621-6. PubMed ID: 3713759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Translating research into licensed vaccines and validated and licensed diagnostic tests.
    Hill RE; Foley PL; Clough NE; Ludemann LR; Murtle DC
    Dev Biol (Basel); 2013; 135():53-8. PubMed ID: 23689883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The global stem cell patent landscape: implications for efficient technology transfer and commercial development.
    Bergman K; Graff GD
    Nat Biotechnol; 2007 Apr; 25(4):419-24. PubMed ID: 17420745
    [No Abstract]   [Full Text] [Related]  

  • 33. Found in translation; from the laboratory to the operating room to the market.
    Galloway RL
    Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():5162-5. PubMed ID: 18003170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Policy on 180-day marketing exclusivity for drugs marketed under abbreviated new drug applications; clarification--FDA. Clarification.
    Fed Regist; 1997 Nov; 62(229):63268-9. PubMed ID: 10177950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can patents prohibit research? On the social epistemology of patenting and licensing in science.
    Biddle JB
    Stud Hist Philos Sci; 2014 Mar; 45():14-23. PubMed ID: 24984445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Entrepreneurship.
    Yetisen AK; Volpatti LR; Coskun AF; Cho S; Kamrani E; Butt H; Khademhosseini A; Yun SH
    Lab Chip; 2015; 15(18):3638-60. PubMed ID: 26245815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Translational science: past, present, and future.
    Curry SH
    Biotechniques; 2008 Feb; 44(2):ii-viii. PubMed ID: 18422489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Applications for FDA approval to market a dew drug: patent submission and listing requirements and application of 30-month stays on approval of abbreviated new drug applications certifying that a patent claiming a drug is invalid or will not be infringed. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Jun; 68(117):36675-712. PubMed ID: 12814136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clearing up the hazy road from bench to bedside: a framework for integrating the fourth hurdle into translational medicine.
    Rogowski WH; Hartz SC; John JH
    BMC Health Serv Res; 2008 Sep; 8():194. PubMed ID: 18816378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmaceutical marketing in a new age. Effective campaigns still need to focus on what customers want.
    Rao SK
    Mark Health Serv; 2002; 22(1):6-12. PubMed ID: 11881547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.